AVNS Stock Analysis: Buy, Sell, or Hold?
AVNS - Avanos Medical, Inc.
$24.93
0.30 (1.22%)
▲
5d:
+0.12%
30d:
-0.24%
90d:
+76.93%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
30d
Get Alerted When AVNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AVNS shows positive signals but monitor for confirmation. Market pricing in 9.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: AVNS shows positive signals but monitor for confirmation. Market pricing in 9.4% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.00
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.97
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVNS is currently trading at $24.93, which is considered fair relative to its 30-day fair value range of $24.82 to $25.02. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.9) compared to its historical average (15.2). At these levels, the market is pricing in 9.4% annual earnings growth.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is currently testing key support at $24.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $14.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is currently testing key support at $24.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $14.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$24.82 -
$25.02
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 43.8% above Wall St target ($14.00)
- BULLISH: Expecting earnings turnaround to 9.4% growth with 8.8% revenue growth
Trading Range Analysis
30-Day Trading Range
$24.82 -
$25.02
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$24.46
Resistance Level
$24.99
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.94
Wall Street Target
$14.00
(-43.8%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
-21.7%
Profit Margin
-10.4%
Valuation Premium vs History
+9.4% premium
PE vs Historical
19.9 vs 15.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.4%
(market-implied from PE analysis)
1-Year Target
$27.27
(+9%)
2-Year Target
$29.84
(+20%)
3-Year Target
$32.64
(+31%)
3-Yr Target (if PE normalizes)
(PE: 20→15)
PE COMPRESSION
$24.88
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 25.0%)
$53.17
(+113%)
Base:
(SPY PE: 19.9, Growth: 25.0%)
$48.69
(+95%)
Bear:
(PE: 15.2, Growth: 25.0%)
$37.11
(+49%)
Share & Embed Analysis
Last updated: July 04, 2026 5:40 PM ET
Data refreshes hourly during market hours. Next update: 6:40 PM
Data refreshes hourly during market hours. Next update: 6:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
